DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 123 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,854,785 | +0.5% | 2,188,654 | -2.2% | 2.01% | +9.9% |
Q2 2023 | $26,711,105 | +24.6% | 2,237,111 | +39.5% | 1.83% | +12.1% |
Q1 2023 | $21,437,324 | +26.6% | 1,603,390 | +103.8% | 1.63% | +9.8% |
Q4 2022 | $16,926,642 | +11.6% | 786,554 | +3.8% | 1.48% | +5.5% |
Q3 2022 | $15,171,000 | – | 757,407 | – | 1.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners XI LLC | 6,964,301 | $139,495,000 | 56.26% |
PATHWAY CAPITAL MANAGEMENT, LP | 403,127 | $8,075,000 | 25.88% |
Atlas Venture Life Science Advisors, LLC | 8,169,171 | $163,628,000 | 18.06% |
RA Capital Management | 7,040,622 | $141,024,000 | 3.01% |
COMMODORE CAPITAL LP | 739,661 | $14,815,000 | 2.38% |
Nicholas Investment Partners, LP | 757,407 | $15,171,000 | 1.41% |
Boxer Capital, LLC | 1,189,943 | $23,835,000 | 1.34% |
Parkman Healthcare Partners LLC | 212,191 | $4,250,000 | 1.21% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $8,012,000 | 0.98% |
Samsara BioCapital, LLC | 196,425 | $3,934,000 | 0.92% |